FMO5 and cardiovascular disorder: Specifically, NADPH oxidases, and their interaction with the mitochondria [45], should be mentioned, as they are generally considered as major producers of reactive oxygen species (ROS) and have been involved in both renal and cardiovascular disorders, and therapeutic strategies damping their activity may have potential benefits [46].